← All trials
NCT06658093
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2025
- Primary completion
- Mar 31, 2029
- Completion date
- Aug 31, 2029
- First posted
- Oct 26, 2024
- Last posted
- Oct 26, 2024
- Enrollment
- 194
- Arms / groups
- 7 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of Texas, San AntonioLead sponsor
- National Institute on Aging (NIA)Collaborator
- University of Texas, San AntonioOfficial
- University of Texas, San AntonioSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.